A federal board that’s warned of spiralling drug prices is commissioning a survey of consumer costs in 21 countries worldwide. The Patented Medicine Prices Review Board has cautioned Canadians will soon pay the second-highest drug prices outside the U.S.: “We have been creeping up”.